Sign inGet started

SXTP

60 DEGREES PHARMACEUTICALS, INC.CIK 1946563 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
8

AI insights for SXTP PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for SXTP
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
DOW GEOFFREY SPresident and CEO22$136.2K$02026-06-12
XU CHERYLDirector15$122.3K$02025-06-03
Landon KristenChief Operating Officer2$0$02025-01-17
MILLER TYRONEChief Financial Officer8$0$02025-01-17
TOOVEY STEPHENDirector3$0$02024-05-16
FIELD PAULDirector3$0$02024-05-16
Allen Charles WDirector3$0$02024-05-16
KNIGHT THERAPEUTICS INTERNATIONAL SAOther2$0$02023-07-28

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
DOW GEOFFREY SPresident and CEO P Buy2026-06-122026-06-157,350$1.38 $10.1K24,131SEC↗
DOW GEOFFREY SPresident and CEO P Buy2025-12-152025-12-169,670$0.80 $7.7K59,618SEC↗
DOW GEOFFREY SPresident and CEO P Buy2025-12-112025-12-123,613$0.92 $3.3K49,948SEC↗
DOW GEOFFREY SPresident and CEO P Buy2025-12-102025-12-129,350$0.95 $8.9K46,335SEC↗
DOW GEOFFREY SPresident and CEO A Award2025-09-122025-09-157,201$1.39 $10.0K33,372SEC↗
DOW GEOFFREY SPresident and CEO A Award2025-06-092025-06-094,376$2.99 $13.1K26,171SEC↗
XU CHERYLDirector P Buy2025-06-032025-06-053,000$2.87 $8.6K13,816SEC↗
XU CHERYLDirector P Buy2025-06-032025-06-052,000$2.90 $5.8K15,816SEC↗
Landon KristenChief Operating Officer A Award2025-01-172025-08-144,540— $04,540SEC↗
MILLER TYRONECFO A Award2025-01-172025-01-2111,626— $026,370SEC↗
DOW GEOFFREY SPresident and CEO A Award2025-01-172025-01-2114,394— $0108,974SEC↗
MILLER TYRONECFO A Award deriv2025-01-022025-01-2475,000— $075,000SEC↗
DOW GEOFFREY SPresident and CEO A Award deriv2025-01-022025-01-24525,000— $0525,000SEC↗
XU CHERYLDirector P Buy2024-12-162024-12-182,000$1.45 $2.9K54,078SEC↗
XU CHERYLDirector P Buy2024-12-132024-12-181,500$1.60 $2.4K47,578SEC↗
XU CHERYLDirector P Buy2024-12-132024-12-181,500$1.58 $2.4K49,078SEC↗
XU CHERYLDirector P Buy2024-12-132024-12-181,500$1.55 $2.3K50,578SEC↗
XU CHERYLDirector P Buy2024-12-132024-12-181,500$1.52 $2.3K52,078SEC↗
XU CHERYLDirector P Buy2024-12-122024-12-182,500$1.80 $4.5K46,078SEC↗
XU CHERYLDirector P Buy2024-12-122024-12-182,500$1.85 $4.6K43,578SEC↗
DOW GEOFFREY SPresident and CEO P Buy2024-12-092024-12-0935,823$1.27 $45.5K94,580SEC↗
DOW GEOFFREY SPresident and CEO P Buy2024-12-062024-12-0920,579$1.20 $24.7K58,757SEC↗
DOW GEOFFREY SPresident and CEO P Buy2024-12-052024-12-0917,549$1.11 $19.5K38,178SEC↗
DOW GEOFFREY SPresident and CEO P Buy2024-11-212024-11-213,500$0.91 $3.2K20,629SEC↗
DOW GEOFFREY SPresident and CEO P Buy2024-11-202024-11-211,000$0.92 $92017,129SEC↗
DOW GEOFFREY SPresident and CEO P Buy2024-11-192024-11-212,500$0.90 $2.3K16,129SEC↗
Landon KristenChief Operating Officer A Award deriv2024-09-262025-08-144,167— $04,167SEC↗
XU CHERYLDirector P Buy2024-08-272024-09-115,000$1.70 $8.5K41,078SEC↗
Allen Charles WDirector M Exercise deriv2024-05-162024-05-214,000— $04,000SEC↗
DOW GEOFFREY SPresident and CEO M Exercise deriv2024-05-162024-05-2117,000— $00SEC↗
FIELD PAULDirector M Exercise deriv2024-05-162024-05-214,000— $04,000SEC↗
MILLER TYRONECFO M Exercise deriv2024-05-162024-05-2115,000— $00SEC↗
TOOVEY STEPHENDirector M Exercise deriv2024-05-162024-05-214,000— $04,000SEC↗
XU CHERYLDirector M Exercise deriv2024-05-162024-05-212,000— $00SEC↗
Allen Charles WDirector M Exercise2024-05-162024-05-214,000$0.22 $88014,000SEC↗
DOW GEOFFREY SPresident and CEO M Exercise2024-05-162024-05-2117,000$0.22 $3.7K762,625SEC↗
FIELD PAULDirector M Exercise2024-05-162024-05-214,000$0.22 $88014,000SEC↗
MILLER TYRONECFO A Award2024-05-162024-05-2115,000$0.22 $3.3K176,928SEC↗
TOOVEY STEPHENDirector A Award2024-05-162024-05-214,000$0.22 $88014,000SEC↗
XU CHERYLDirector M Exercise2024-05-162024-05-212,000$0.22 $440228,934SEC↗
DOW GEOFFREY SPresident and CEO M Exercise deriv2024-04-122024-05-2168,000— $017,000SEC↗
MILLER TYRONECFO M Exercise deriv2024-04-122024-05-2160,000— $015,000SEC↗
DOW GEOFFREY SPresident and CEO M Exercise2024-04-122024-05-2168,000$0.27 $18.4K745,625SEC↗
MILLER TYRONECFO A Award2024-04-122024-05-2160,000$0.27 $16.2K161,928SEC↗
XU CHERYLDirector M Exercise2024-02-012024-02-022,000— $06,000SEC↗
XU CHERYLDirector P Buy deriv2024-01-312024-02-02200,000$0.01 $2.0K200,000SEC↗
DOW GEOFFREY SPresident and CEO P Buy deriv2024-01-312024-02-0225,974$0.01 $26025,974SEC↗
XU CHERYLDirector P Buy2024-01-312024-02-02200,000$0.38 $76.0K424,934SEC↗
DOW GEOFFREY SPresident and CEO P Buy2024-01-312024-02-0225,974$0.38 $9.9K703,599SEC↗
Allen Charles WDirector A Award deriv2023-12-312024-05-214,000— $04,000SEC↗
FIELD PAULDirector A Award deriv2023-12-312024-05-214,000— $04,000SEC↗
TOOVEY STEPHENDirector A Award deriv2023-12-312024-05-214,000— $04,000SEC↗
DOW GEOFFREY SPresident and CEO A Award deriv2023-11-212024-05-2185,000— $085,000SEC↗
MILLER TYRONECFO A Award deriv2023-11-212024-05-2175,000— $075,000SEC↗
KNIGHT THERAPEUTICS INTERNATIOOther C Conversion2023-07-282024-04-0345,560$4.75 $216.4K1,153,897SEC↗
KNIGHT THERAPEUTICS INTERNATIOOther C Conversion2023-07-282024-04-032,162— $078,803SEC↗
DOW GEOFFREY SPresident and CEO A Award deriv2023-07-122023-07-12300,000— $0300,000SEC↗
MILLER TYRONEChief Financial Officer A Award deriv2023-07-122023-07-12240,000— $0240,000SEC↗